Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-112507·D. E. SHAW & CO, L.P.
Schedule 13G ownership disclosure
Sarepta Therapeutics Inc
Common Stock, $0.0001 par value per share · CUSIP: 803607100
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- D. E. Shaw & Co., L.P.
Shares: 2,007,025.00 · Class: 1.9%
- David E. Shaw
Shares: 2,007,025.00 · Class: 1.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-112507
- Form type
- SCHEDULE 13G/A
- Filer
- D. E. SHAW & CO, L.P.
- CIK
- CIK 1009268
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership